Advertisement

Medical and Other Psychiatric Conditions Potentially Misdiagnosed as Schizophrenia

  • C. Raymond Lake
Chapter

Abstract

Although psychotic mood disorders likely account for a large majority of misdiagnoses of schizophrenia, many medical disorders, medications, drugs, and some other psychiatric disorders can present with psychotic features that can also lead to misdiagnoses of schizophrenia or a mood disorder. Hall et al. (1978) reported an incidence of medical disorders in 9.1% of 658 consecutive psychiatric outpatients that they felt caused the patients’ psychiatric symptoms. Such patients were most commonly misdiagnosed with schizophrenia and depression. A similarly designed study found 5.6% of first-episode patients diagnosed with schizophrenia had an unrecognized medical disorder that explained psychotic symptoms (Johnstone et al. 1987).

Keywords

Psychotic Symptom Antipsychotic Medication Tardive Dyskinesia Chronic Traumatic Encephalopathy Mood Symptom 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Adachi, N., Ito, M., Kanemoto, K., et al. (2007). Duration of postictal psychotic episodes. Epilepsia, 48, 1531–1537.PubMedCrossRefGoogle Scholar
  2. Arzy, S., Seeck, M., Ortigue, S., Spinelli, L., & Blanke, O. (2006). Induction of an illusory shadow person. Nature, 443, 287.PubMedCrossRefGoogle Scholar
  3. Bentall, R. P. (1990). The illusion of reality: A review and integration of psychological research on hallucinations. Psychological Bulletin, 107, 82–95.PubMedCrossRefGoogle Scholar
  4. Bentall, R. (2004, March 20–23). Roll over Kraepelin, Mental Health Today.Google Scholar
  5. Bentall, R. (2006). Madness explained: why we must reject the Kraepelinian paradigm and replace it with a ‘complaint-oriented’ approach to understanding mental illness. Medical Hypotheses, 66, 220–233.PubMedCrossRefGoogle Scholar
  6. Bentall, R. P., & Fernyhough, C. (2008). Social predictors of psychotic experiences: specificity and psychological mechanisms. Schizophrenia Bulletin, 34, 1012–1020.PubMedCrossRefGoogle Scholar
  7. Bentall, R. P., Jackson, H. F., & Pilgrim, D. (1988). Abandoning the concept of ‘schizophrenia:’ some implications of validity arguments for psychological research into psychotic phenomena. The British Journal of Clinical Psychology, 27, 303–324.PubMedCrossRefGoogle Scholar
  8. Bottas, A., Cooke, R. G., & Richter, M. A. (2005). Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: Is there evidence for a schizo-obsessive subtype of schizophrenia? Journal of Psychiatry & Neuroscience, 30, 187–193.Google Scholar
  9. Carlson, G. A., & Goodwin, F. K. (1973). The stages of mania. A longitudinal analysis of the manic episode. Archives of General Psychiatry, 28, 221–228. (Chaps. 1, 8).PubMedCrossRefGoogle Scholar
  10. Caton, C. L., Drake, R. E., Hasin, D. S., et al. (2005). Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Archives of General Psychiatry, 62, 135–145. (Published correction appears in Archives of General Psychiatry. 2005;62:493).CrossRefGoogle Scholar
  11. Chouinard, G., & Jones, B. (1980). Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics. The American Journal of Psychiatry, 137, 16–20. (Chap. 14).PubMedGoogle Scholar
  12. Devinsky, O. (2008). Postictal psychosis: Common, dangerous, and treatable. Epilepsy Curr, 8, 31–34.PubMedCrossRefGoogle Scholar
  13. Doran, A. R., Breier, A., & Roy, A. (1986). Differential diagnosis and diagnostic systems in Schizophrenia. Psychiatric Clinics of North America, 9, 17–33. (Chaps 2, 8).PubMedGoogle Scholar
  14. Douglas, A. B. (2003). Narcolepsy: Differential diagnosis or etiology in some cases of bipolar disorder and schizophrenia? CNS Spectrums, 8, 120–126.Google Scholar
  15. Downs, J. M., Akiskal, H. G., & Rosenthal, T. L. (1993) Presented at the Annual Meeting of the American Psychiatric Association. Abstract 146.Google Scholar
  16. Freudenreich, O. (2010). Differential diagnosis of psychotic symptoms: Medical “mimics. Psychiatric Times, XXVII, 56–61.Google Scholar
  17. Freudenreich, O., Holt, D. J., Cather, C., & Goff, D. C. (2007). The evaluation and management of patients with first-episode schizophrenia: A selective, clinical review of diagnosis, treatment and prognosis. Harvard Review of Psychiatry, 15, 189–211.PubMedCrossRefGoogle Scholar
  18. Goodwin, F. K. (1989). The biology of recurrence: New directions for the pharmacologic bridge. The Journal of Clinical Psychiatry, 50, 40–44. (Chaps. 8, 9, 10, 18).PubMedGoogle Scholar
  19. Hall, R. C. W., Popkin, M. K., DeVaul, M. K., et al. (1978). Physical illness presenting as psychiatric disease. Archives of General Psychiatry, 35, 1315–1320.PubMedCrossRefGoogle Scholar
  20. Honig, A., Romme, M. A. J., Ensink, B. J., Escher, S. D., Pennings, M. H., & Devries, M. W. (1998). Auditory hallucinations: A comparison between patients and non-patients. The Journal of Nervous and Mental Disease, 186, 646–651.PubMedCrossRefGoogle Scholar
  21. Hwang, M. Y., Yum, S. Y., Kwon, J. S., & Opler, L. A. (2005). Management of schizophrenia with obsessive-disorder. Psychiatric Annals, 35, 36–43.Google Scholar
  22. Johnstone, E. C., Macmillan, J. F., & Crow, T. J. (1987). The occurrence of organic disease of possible or probable aetiological significance in a population of 268 cases of first episode schizophrenia. Psychological Medicine, 17, 371–379. (Chap. 14).PubMedCrossRefGoogle Scholar
  23. Kendell, R. E., & Gourlay, J. (1970a). The clinical distinction between psychotic and neurotic depressions. The British Journal of Psychiatry, 117, 257–260. (Chap. 8).PubMedGoogle Scholar
  24. Kendell, R. E., & Gourlay, J. (1970b). The clinical distinction between the affective psychoses and schizophrenia. The British Journal of Psychiatry, 117, 261–266. (Chap. 8).PubMedGoogle Scholar
  25. Kendler, K. S., Gallagher, T. J., Ableson, J. M., & Kessler, R. C. (1996). Lifetime prevalence, demographic risk factors and diagnostic validity of non-affective psychosis as assessed in a US community sample. Archives of General Psychiatry, 53, 1022–1031. (Chap. 14).PubMedCrossRefGoogle Scholar
  26. Lake, C. R. (2008c). How academic psychiatry can better prepare our students for their future patients: Part I: The failure to recognize depression and risk for suicide in primary care; problem identification, responsibility and solutions. Behavioral Medicine, 34, 95–100.PubMedCrossRefGoogle Scholar
  27. Lake, C. R. (2008d). How academic psychiatry can better prepare our students for their future patients: Part II: A course in ultra-brief initial diagnostic screening suitable for future primary care physicians. Behavioral Medicine, 34, 101–116.PubMedCrossRefGoogle Scholar
  28. Lenggenhager, B., Tadi, T., Mdtzinger, T., & Blanke, O. (2007). Video ergo sum: Manipulating bodily self-consciousness. Science, 317, 1096–1099.PubMedCrossRefGoogle Scholar
  29. Lu, M. L., Pan, J. J., Tang, H. W., Su, K. P., & Shen, W. W. (2002). Metoclopramide-induced supersensitivity psychosis. The Annals of Pharmacotherapy, 36, 1387–1390. (Chap. 12).PubMedCrossRefGoogle Scholar
  30. Mahgoub, N., & Serby, M. (2007). Charles Bonnet syndrome: Long-term outcome of treatment. Psychiatric Annals, 37, 579–580.Google Scholar
  31. Martin, M. J. (1983). A brief review of organic diseases masquerading as functional illness. Hospital & Community Psychiatry, 34, 328–332. (Chap. 10).Google Scholar
  32. Moore, R., Blackwood, N., Corcoran, R., Rowse, G., Kinderman, P., Bentall, R., & Howard, R. (2006). Misunderstanding in the intentions of others: an exploratory study of the cognitive etiology of persecutory delusions in very late-onset schizophrenia-like psychosis. The American Journal of Geriatric Psychiatry, 14, 410–418.PubMedCrossRefGoogle Scholar
  33. Moynihan, R., Heath, I., & Henry, D. (2002). Selling sickness: The pharmaceutical industry and disease mongering. British Medical Journal, 324, 886–891.PubMedCrossRefGoogle Scholar
  34. Perea, E., Robbins, B. V., & Hutto, B. (2006). Psychosis related to ropinirole. The American Journal of Psychiatry, 163, 547–548.PubMedCrossRefGoogle Scholar
  35. Pini, S., Cassano, G. B., Dell’Osso, L., & Amador, X. F. (2001). Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features. The American Journal of Psychiatry, 158, 122–125. (Chaps. 8, 9).PubMedCrossRefGoogle Scholar
  36. Pope, H. G. (1983). Distinguishing bipolar disorder from schizophrenia in clinical practice: Guidelines and case reports. Hospital & Community Psychiatry, 34, 322–328. (Chaps. 1, 8).Google Scholar
  37. Pope, H. G., & Katz, D. L. (1988). Affective and psychotic symptoms associated with anabolic steroid use. The American Journal of Psychiatry, 145, 487–490.PubMedGoogle Scholar
  38. Pope, H. G., & Lipinski, J. F. (1978). Diagnosis in schizophrenia and manic-depressive illness, a reassessment of the specificity of “schizophrenic” symptoms in the light of current research. Archives of General Psychiatry, 35, 811–828.PubMedCrossRefGoogle Scholar
  39. Post, R. M. (1992). Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. The American Journal of Psychiatry, 149, 999–1010. (Chap. 8).PubMedGoogle Scholar
  40. Poyurovsky, M., Fuchs, C., & Weizman, A. (1999). Obsessive-compulsive disorder in patients with first-episode schizophrenia. The American Journal of Psychiatry, 156, 1998–2000.PubMedGoogle Scholar
  41. Rottnek, M., Riggio, S., Byne, W., Sano, M., Margolis, R. L., & Walker, R. H. (2008). Schizophrenia in a patient with spinocerebellar ataxia 2: Coincidence of two disorders or a neurodegenerative disease presenting with psychosis? The American Journal of Psychiatry, 165, 964–967.PubMedCrossRefGoogle Scholar
  42. Steiner, W., Laporta, M., & Chouinard, G. (1990). Neuroleptic-induced supersensitivity psychosis in patients with bipolar affective disorder. Acta Psychiatrica Scandinavica, 81, 437–440. (Chap. 12).PubMedCrossRefGoogle Scholar
  43. Swartz, C. M. (1995). Tardive psychopathology. Neuropsychobiology, 32, 115–119. (Chap. 12).PubMedCrossRefGoogle Scholar
  44. Swartz, C. M. (2001). Misdiagnosis of schizophrenia for a patient with epilepsy. Psychiatry Services, 52, 109–110. (Chap. 12).CrossRefGoogle Scholar
  45. Swartz, C. M. (2004, October). Antipsychotic psychosis. Psychiatric Times, pp. 17–20. (Chap. 12).Google Scholar
  46. Tibbo, P., Kroetsch, M., Chue, P., & Warneke, L. (2000). Obsessive-compulsive disorder in schizophrenia. Journal of Psychiatric Research, 34, 139–146.PubMedCrossRefGoogle Scholar
  47. van Os, J., Hanssen, M., Bijl, R. V., & Ravelli, A. (2000). Strauss (1969) revisited: A psychosis continuum in the general population? Schizophrenia Research, 45, 11–20.PubMedCrossRefGoogle Scholar
  48. Verdoux, H., & van Os, J. (2002). Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophrenia Research, 54, 59–65.PubMedCrossRefGoogle Scholar
  49. Viguera, A. C., Baldessarini, R. J., Hegarty, J. D., van Kammen, D. P., & Tohen, M. (1997). Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Archives of General Psychiatry, 54, 49–55. (Chap. 12).PubMedCrossRefGoogle Scholar
  50. Weinberger, D. R., Bigelow, L., Klein, S. T., & Wyatt, R. J. (1981). Drug withdrawal in chronic schizophrenia patients: In search of neuroleptic induced supersensitivity psychosis. Journal of Clinical Psychopharmacology, 1, 120–123. (Chap. 12).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department Psychiatry and Behavioral SciencesUniversity of Kansas, School of MedicineKansas CityUSA

Personalised recommendations